BIO-RAD LABORATORIES, INC. Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Bio Rad Laboratories, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q3 2025.
  • Bio Rad Laboratories, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2025 was $180M, a 3.7% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)

BIO-RAD LABORATORIES, INC. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $180M +$6.43M +3.7% Sep 30, 2025 10-Q 2025-10-29
Q2 2025 $190M +$8.93M +4.92% Jun 30, 2025 10-Q 2025-07-31
Q1 2025 $153M -$35.7M -18.9% Mar 31, 2025 10-Q 2025-05-01
Q4 2024 $161M -$34.2M -17.6% Dec 31, 2024 10-Q 2025-10-29
Q3 2024 $174M -$26.1M -13.1% Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $181M +$7.55M +4.34% Jun 30, 2024 10-Q 2024-08-02
Q1 2024 $189M +$14.8M +8.51% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $195M +$13.7M +7.6% Dec 31, 2023 10-K 2025-02-14
Q3 2023 $200M +$28.4M +16.6% Sep 30, 2023 10-Q 2023-10-27
Q2 2023 $174M -$11.2M -6.06% Jun 30, 2023 10-Q 2023-08-04
Q1 2023 $174M -$24.4M -12.3% Mar 31, 2023 10-Q 2023-05-05
Q4 2022 $181M -$23.8M -11.6% Dec 31, 2022 10-K 2024-02-16
Q3 2022 $172M -$32.6M -16% Sep 30, 2022 10-Q 2022-10-28
Q2 2022 $185M -$5.08M -2.67% Jun 30, 2022 10-Q 2022-07-29
Q1 2022 $198M +$2.23M +1.14% Mar 31, 2022 10-Q 2022-04-29
Q4 2021 $205M +$2.66M +1.32% Dec 31, 2021 10-K 2023-02-17
Q3 2021 $204M +$7.54M +3.83% Sep 30, 2021 10-Q 2021-10-29
Q2 2021 $190M -$7.36M -3.72% Jun 30, 2021 10-Q 2021-07-30
Q1 2021 $196M -$4.26M -2.13% Mar 31, 2021 10-Q 2021-04-30
Q4 2020 $202M +$268K +0.13% Dec 31, 2020 10-K 2022-02-11
Q3 2020 $197M -$20.9M -9.59% Sep 30, 2020 10-Q 2020-10-30
Q2 2020 $198M -$17.9M -8.32% Jun 30, 2020 10-Q 2020-07-31
Q1 2020 $200M -$21.1M -9.53% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 $202M +$202M Dec 31, 2019 10-K 2021-02-16
Q3 2019 $218M Sep 30, 2019 10-Q 2019-11-01
Q2 2019 $216M Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $222M Mar 31, 2019 10-Q 2019-05-10
Q4 2018 $0 Dec 31, 2018 10-K 2020-03-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.